Myeongjin Choi

1.3k citations
33 papers · 779 indexed · h-index 15
Topics
Antibiotic Resistance in Bacteria (11 papers)Bacterial Genetics and Biotechnology (4 papers)Antibiotics Pharmacokinetics and Efficacy (4 papers)
Partner nations
South KoreaUnited States

In The Last Decade

Myeongjin Choi

31 papers receiving 761 citations

Peers

Myeongjin Choi
Comparison fields: 5 of 88
  • Molecular Medicine 303
  • Molecular Biology 174
  • Pharmacology 141
  • Epidemiology 141
  • Endocrinology 121
Replace Manuel Macías with:
Manuel Macías Spain
Yan Jin China
Wenwen Huo China
Buket Baddal Cyprus
Christian Johann Lerche Denmark
Rachel V. Floyd United Kingdom
Marianna Murdjeva Bulgaria
Matthew Stephens Canada
Fuminori Sakai Japan
Hang Liu China
Myeongjin Choi relative to Manuel Macías Spain Manuel Macías's profile →
Citations per field
00.5×5.6×
Manuel Macías · 1×
Citations per year

Countries citing papers authored by Myeongjin Choi

Since Specialization
Citations

This map shows the geographic impact of Myeongjin Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myeongjin Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myeongjin Choi more than expected).

Fields of papers citing papers by Myeongjin Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myeongjin Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myeongjin Choi. The network helps show where Myeongjin Choi may publish in the future.

Co-authorship network of co-authors of Myeongjin Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Myeongjin Choi. A scholar is included among the top collaborators of Myeongjin Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myeongjin Choi. Myeongjin Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 13
4 1
5 2
6 7
7 71
8 4
9 15
10 1
11 24
12 17
13 25
14 16
15 15
16 39
17 4
18 2
19 88
20 154

About Myeongjin Choi

Myeongjin Choi is a scholar working on Molecular Medicine, Clinical Biochemistry and Endocrinology, having authored 33 papers that have together received 779 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (11 papers), Bacterial Genetics and Biotechnology (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Molecular Medicine (303 citations), Endocrinology (121 citations) and Transplantation (54 citations). Myeongjin Choi has collaborated with scholars based in South Korea and United States. Frequent co-authors include Kwan Soo Ko, W. A. Briggs, Alan S. Cross, Raphael Simon, Sharon M. Tennant, Dereje Damte, Seung‐Jin Lee, Seung‐Chun Park, Elias Gebru and Jiyoung Lee. Their work appears in journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026